Complications of Acute Stroke
Lancet 339:721-724, Oppenheimer,S.&Hachinski,V., 1992
Differential Diagnosis of Bilateral Abnormalities of the Basal Ganglia and Thalamus
RadioGraphics 31:5-30, Hegde,A.N.,et al, 2011
Vascular Risk Factors and Diabetic Neuropathy
NEJM 352: 341-350, 408, Tesfaye, S., et al, 2005
Predictors of Hyperacute Clinical Worsening in Ischemic Stroke Patients Receiving Thrombolytic Therapy
Stroke 35:1903-1907, Leigh,R.,et al, 2004
Lack of Improvement in Patients with Acute Stroke After Treatment with Thrombolytic Therapy
JAMA 292:1839-1844, Saposnik,G.,et al, 2004
The Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline
JAMA 292:2237-2242, Yaffe,K.,et al, 2004
Effects of Admission Hyperglycemia on Stroke Outcome in Reperfused Tissue Plasminogen Activator-Treated Patients
Stroke 34:1235-1241, Alvarez-Sabin,J.,et al, 2003
Admission Glucose Level and Clinical Outcomes in the NINDS rt-PA Stroke Trial
Neurol 59:669-674, Bruno,A.,et al, 2002
Predictors of Stroke in Middle-Aged Patients with Non-Insulin-Dependent Diabetes
Stroke 27:63-68, Lehto,S.,et al, 1996
Deteriorating Ischemic Stroke:Risk Factors and Prognosis
Neurol 40:1865-1869, Davalos,A.,et al, 1990
The Neurologist's Experience with Pheochromocytoma
JAMA 197:100, Thomas,J.E.,et al, 1966